OPEN END TURBO OPTIONSSCHEIN SHORT - ASTRAZENECA | Market Closed - BOERSE MUENCHEN 14:25:54 2024-06-07 EDT | ||
| 0.77 EUR | +4.05% |
|
| Current month | -35.29% | ||
| 1 month | -37.85% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 0.77 | +4.05% |
| 24-06-06 | 0.74 | -9.76% |
| 24-06-05 | 0.82 | -12.77% |
| 24-06-04 | 0.94 | -12.15% |
| 24-06-03 | 1.07 | -10.08% |
Real-time BOERSE MUENCHEN
Last update June 07, 2024 at 02:25 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | Goldman Sachs |
| WKN | GG64L2 |
| ISIN | DE000GG64L22 |
| Date issued | 2024-04-12 |
| Strike | 13,196 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.56 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.768 € |
|---|---|
| Lowest since issue | 0.722 € |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
159.8
USD
Average target price
173.2
USD
Spread / Average Target
+8.39%
- Stock Market
- Certificates
- Certificat
